Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Haydn T. Kissick"'
Autor:
Kenneth Ogan, Greta Russler, Jamie M. Goldman, Bassel Nazha, Benjamin Magod, Bradley C. Carthon, Deepak Ravindranathan, Shreyas S. Joshi, Haydn T. Kissick, Yuan Liu, T. Anders Olsen, Wayne Harris, Julie M. Shabto, Omer Kucuk, Jacqueline T. Brown, Subir Goyal, Sarah Caulfield, Lauren Yantorni, Mehmet Asim Bilen, Viraj A. Master, Sean Evans, Dylan J. Martini
Publikováno v:
Oncologist
Background Several immune checkpoint inhibitors (ICIs) are approved for the treatment of advanced urothelial carcinoma (UC). There are limited biomarkers for ICI-treated patients with UC. We investigated the association between body composition and c
Autor:
Yuan Liu, Julie M. Shabto, Bradley C. Carthon, Lauren Yantorni, Viraj A. Master, Dylan J. Martini, Omer Kucuk, Kenneth Ogan, Mehmet Asim Bilen, Shreyas S. Joshi, Jacqueline T. Brown, Deepak Ravindranathan, Wayne Harris, Sarah Caulfield, Haydn T. Kissick, Emilie Elise Hitron, Greta Russler
Publikováno v:
Oncologist
Background The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C-reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved fo
Autor:
Pragati Sharma, Mohit Singla, Kamalvishnu P. Gottimukkala, Rakesh Lodha, Pushpendra Singh, Sivaram Gunisetty, Sanjeev Kumar, Priya Bhatnagar, Anmol Chandele, Guruprasad R. Medigeshi, Harekrushna Panda, Kaja Murali-Krishna, Yadya M Chawla, Kaustuv Nayak, Charu Aggarwal, Rafi Ahmed, Carl W. Davis, Sushil K. Kabra, Keshav Saini, Elluri Seetharami Reddy, Haydn T. Kissick, Deepti Maheshwari
Publikováno v:
J Virol
Previous studies have shown that plasmablasts expand massively in dengue patients as compared to many other situations such as influenza infection or vaccination. However, a detailed understanding of the phenotypes and transcriptional features of the
Autor:
Haydn T. Kissick, Maria Cardenas, Jennifer W Carlisle, Adeboye O. Osunkoya, Caroline S. Jansen, Viraj A. Master, Patrick Mullane, Mehmet Asim Bilen, Rachel Greenwald, Ewelina Sobierajska, Nataliya Prokhnevska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundTumor infiltrating T-cells have a prognostic benefit in many tumor types,1–8 and we recently sought to determine whether the level of T-cell infiltration into renal tumors predicts clinical outcomes. In our recent publication,9 we showed
Autor:
Edmund K. Waller, Maria Cardenas, Gregory B. Lesinski, Bassel F. El-Rayes, Jingru Zhu, Mohammad Y. Zaidi, Shuhua Wang, Brian S. Robinson, Michael B. Ware, Susan N. Thomas, Yuan Liu, Tenzin Passang Fnu, Shanmuganathan Chandrakasan, Sruthi Ravindranathan, Jian-Ming Li, Alan B. Frey, Rohan K. Dhamsania, Sanjeev Gumber, Anish Majumdar, Haydn T. Kissick
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPaucity of T cells in the immune privileged tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) is a major reason that PDAC is refractory to immune checkpoint blockade.1 In this study, we show that human PDAC tumors over
Autor:
Mehmet Asim Bilen, Yuan Liu, Sarah Caulfield, Julie M. Shabto, Bradley C. Carthon, Viraj A. Master, Wayne Harris, Omer Kucuk, Dylan J. Martini, Haydn T. Kissick, Greta Russler, Emilie Elise Hitron
Publikováno v:
The Oncologist
Background The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) criteria are the gold standard for risk‐stratifying patients with metastatic renal cell cancer (mRCC). We developed a novel risk scoring system for patients wit
Autor:
David H. Lawson, Haydn T. Kissick, R. Donald Harvey, Jacqueline T. Brown, Colleen Lewis, Olatunji B. Alese, Ragini R. Kudchadkar, Bassel F. El-Rayes, Mehmet Asim Bilen, Walid L. Shaib, Christina Wu, Amir Ishaq Khan, Yuan Liu, Julie M. Shabto, Hannah Collins, Rathi N. Pillai, Suresh S. Ramalingam, Milton Williams, Alexandra Speak, Viraj A. Master, Dylan J. Martini, Conor E. Steuer, Bradley C. Carthon, Mehmet Akce, Taofeek K. Owonikoko
Publikováno v:
The Oncologist
Oncologist
Oncologist
Background Sarcopenia and inflammation have been associated with poor survival in patients with cancer. We explored the combined effects of these variables on survival in patients with cancer treated with immunotherapy. Methods We performed a retrosp
Autor:
Milton Williams, Viraj A. Master, Olatunji B. Alese, David H. Lawson, Christina Wu, Ragini R. Kudchadkar, Hannah Collins, Yuan Liu, Amir Ishaq Khan, Dylan J. Martini, Conor E. Steuer, Haydn T. Kissick, Mehmet Akce, Bradley C. Carthon, Bassel F. El-Rayes, R. Donald Harvey, Colleen Lewis, Julie M. Shabto, Suresh S. Ramalingam, Taofeek K. Owonikoko, Meredith R Kline, Mehmet Asim Bilen, Rathi N. Pillai, Walid L. Shaib
Publikováno v:
Cancer. 126:575-582
BACKGROUND Body mass index (BMI) is used to define obesity, but it is an imperfect measure of body composition. In the current study, the authors explored the association between types of fat and survival in patients treated with immunotherapy. METHO
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod, Jacqueline T. Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M. Goldman, Bassel Nazha, Haydn T. Kissick, Wayne B. Harris, Omer Kucuk, Bradley C. Carthon, Viraj A. Master, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundImmune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Biomarkers for mRCC patients treated with ICI are limited, and body composition is underutilized in mRCC. We investigated the as
Autor:
Wayne Harris, Bradley C. Carthon, Shreyas S. Joshi, Julie M. Shabto, Deepak Ravindranathan, Jacqueline T. Brown, Omer Kucuk, Sarah Caulfield, Kenneth Ogan, Dylan J. Martini, Viraj A. Master, Haydn T. Kissick, Lauren Yantorni, Emilie Elise Hitron, Mehmet Asim Bilen, Yuan Liu, Greta Russler, Bassel Nazha
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
BackgroundThe modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRCC